Kimberly-Clark shareholders have approved the acquisition of Kenvue. The deal is set to expand Kimberly-Clark's global health ...

The job cuts arrive as Kimberly-Clark pursues a roughly $48.7 billion cash and stock acquisition of Kenvue that would roll household names like Tylenol, Band-Aid and Listerine into a larger consumer ...

Kimberly-Clark (NASDAQ:KMB) leadership outlined its “Powering Care” strategy and the company’s preparations for its pending ...

The company's board approved a plan to reduce the Kenvue workforce by 3.5%, which will result in hundreds of layoffs.

Kimberly-Clark Corporation (NASDAQ:KMB) is one of the best long-term retirement stocks. On January 29, shareholders approved ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.Kenvue shareholders will receive $3.50 per share in ...

The job cuts are part of a restructuring plan to optimize its operating model and drive operational efficiencies, the company ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Kimberly-Clark Corp. (NASDAQ: KMB) is undergoing the largest transformation in its 150-year history while maintaining a dividend that has increased for 54 consecutive years. The company yields 4.83% ...